421 related articles for article (PubMed ID: 34476752)
21. Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.
Abu-Rumeileh S; Abdelhak A; Foschi M; Tumani H; Otto M
J Neurol; 2021 Apr; 268(4):1133-1170. PubMed ID: 32840686
[TBL] [Abstract][Full Text] [Related]
22. Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.
Akçay N; Menentoğlu ME; Bektaş G; Şevketoğlu E
J Med Virol; 2021 Sep; 93(9):5599-5602. PubMed ID: 33851741
[TBL] [Abstract][Full Text] [Related]
23. Clinical features and real-world outcomes of Guillain-Barré syndrome in the Philippines.
I Espiritu A; Separa KJNJ; Milla FJC; Adiao KJB; Leochico CFD; Jamora RDG
Neurol Res; 2021 Dec; 43(12):995-1004. PubMed ID: 34229572
[TBL] [Abstract][Full Text] [Related]
24. Anti-ganglioside complex antibody profiles in a recurrent complicated case of GQ1b-seronegative miller fisher syndrome and Bickerstaff brainstem encephalitis: a case report.
Ito H; Hatanaka Y; Fukami Y; Harada Y; Kobayashi R; Okada H; Uchibori A; Chiba A; Okuda S
BMC Neurol; 2018 May; 18(1):72. PubMed ID: 29792178
[TBL] [Abstract][Full Text] [Related]
25. The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit.
Diaz P; Leveque M; Hautecloque G; Sellal F; Augereau O; Lita L; Biegle E; Belilita L; Bouterra C; Rerat P; Alvarez-Gonzalez A; Martinot M; Gerber V
J Neuroimmunol; 2022 May; 366():577842. PubMed ID: 35339941
[TBL] [Abstract][Full Text] [Related]
26. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
[TBL] [Abstract][Full Text] [Related]
27. [COVID-19-associated Guillain-Barré syndrome in infectious period: a case report].
Nishida K; Sakashita K; Uchibori A; Chiba A; Futamura N
Rinsho Shinkeigaku; 2022 Apr; 62(4):293-297. PubMed ID: 35354729
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of Guillain-Barré syndrome.
Hughes RA; Hadden RD; Gregson NA; Smith KJ
J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
[TBL] [Abstract][Full Text] [Related]
29. Concomitant Guillain-Barré Syndrome and COVID-19: A Meta-Analysis of Cases.
Bentley SA; Ahmad S; Kobeissy FH; Toklu HZ
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557036
[No Abstract] [Full Text] [Related]
30. Guillain-Barre syndrome associated to COVID-19 infection: a review of published case reports.
Zuberbühler P; Conti ME; León-Cejas L; Maximiliano-González F; Bonardo P; Miquelini A; Halfon J; Martínez J; Gutiérrez MV; Reisin R
Rev Neurol; 2021 Mar; 72(6):203-212. PubMed ID: 33710610
[TBL] [Abstract][Full Text] [Related]
31. Guillain-Barré Syndrome After COVID-19 Infection in Korea: A Case Series.
Ryoo N; Son H; Kim JH; Bae DW; An JY
J Korean Med Sci; 2024 Feb; 39(5):e48. PubMed ID: 38317448
[TBL] [Abstract][Full Text] [Related]
32. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
33. [Pathophysiological and diagnostic aspects of Guillain-Barré syndrome].
Carpentier VT; Le Guennec L; Fall SAA; Viala K; Demeret S; Weiss N
Rev Med Interne; 2022 Jul; 43(7):419-428. PubMed ID: 34998626
[TBL] [Abstract][Full Text] [Related]
34. Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review.
Agosti E; Giorgianni A; D'Amore F; Vinacci G; Balbi S; Locatelli D
Neurol Sci; 2021 Feb; 42(2):607-612. PubMed ID: 32643136
[TBL] [Abstract][Full Text] [Related]
35. Bickerstaff's brainstem encephalitis, Miller Fisher syndrome and Guillain-Barré syndrome overlap in an asthma patient with negative anti-ganglioside antibodies.
Han C; Wang Y; Jia J; Ji X; Fredrickson V; Ding Y; Sun W; Xu J; Sun YX
BMC Res Notes; 2012 Jun; 5():295. PubMed ID: 22698187
[TBL] [Abstract][Full Text] [Related]
36. Guillain-Barré syndrome in patients with SARS-CoV-2 infection. Report of three cases.
Cea G; Romero C; Aguilar S; Salinas R
Rev Med Chil; 2021 Dec; 149(12):1812-1816. PubMed ID: 35735350
[TBL] [Abstract][Full Text] [Related]
37. Guillain-Barré syndrome associated with COVID-19: A systematic review.
Pimentel V; Luchsinger VW; Carvalho GL; Alcará AM; Esper NB; Marinowic D; Zanirati G; da Costa JC
Brain Behav Immun Health; 2023 Mar; 28():100578. PubMed ID: 36686624
[TBL] [Abstract][Full Text] [Related]
38. Anti-Ganglioside Antibody-Negative Miller Fisher and AMSAN Variant Guillain-Barré Overlap Syndrome.
Wattanasit P; Sathirapanya P
Case Rep Neurol; 2020; 12(1):92-96. PubMed ID: 32231550
[TBL] [Abstract][Full Text] [Related]
39. Finger Drop-Dominant Variant of Guillain-Barre Syndrome in a Patient With COVID-19: A Case Report.
Kang M; Seok HY
J Korean Med Sci; 2022 May; 37(20):e160. PubMed ID: 35607739
[TBL] [Abstract][Full Text] [Related]
40. [Anti-GD1b IgG positive case of overlapping Ficher's and Guillain-Barré syndromes].
Caudie C; Schandelong A; Rapoport F; Vial C
Ann Biol Clin (Paris); 2004; 62(5):591-4. PubMed ID: 15355812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
